Your browser doesn't support javascript.
loading
A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice.
Yokoyama, Yoko; Matsuoka, Katsuyoshi; Kobayashi, Taku; Sawada, Koji; Fujiyoshi, Tateshi; Ando, Takafumi; Ohnishi, Yoshifumi; Ishida, Tetsuya; Oka, Masashi; Yamada, Masahiro; Nakamura, Takashi; Ino, Tomoko; Numata, Toyoko; Aoki, Hirofumi; Sakou, Jun-Ichi; Kusada, Masahiro; Maekawa, Tomoki; Hibi, Toshifumi.
Afiliação
  • Yokoyama Y; Division of Lower Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.
  • Matsuoka K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
  • Kobayashi T; Center for Advanced IBD Research and Treatment, Kitasato University, Kitasato Institute Hospital, Tokyo, Japan.
  • Sawada K; Ikoma Digestive Tract Internal Medicine Clinic, Osaka, Japan.
  • Fujiyoshi T; Fujiyoshi Clinic, Kumamoto, Japan.
  • Ando T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ohnishi Y; Department of Gastroenterology, National Hospital Organization Shizuoka Medical Center, Shizuoka, Japan.
  • Ishida T; Department of Gastroenterology, Oita Red Cross Hospital, Oita, Japan.
  • Oka M; Department of Gastroenterology and Hepatology, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
  • Yamada M; Department of Gastroenterology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Nakamura T; Japan Operation Division, Blood Purification Business Unit, Scientific and Technical Affairs Department, Asahi Kasei Medical Co. Ltd., Tokyo, Japan.
  • Ino T; Japan Operation Division, Blood Purification Business Unit, Scientific and Technical Affairs Department, Asahi Kasei Medical Co. Ltd., Tokyo, Japan.
  • Numata T; Japan Operation Division, Blood Purification Business Unit, Scientific and Technical Affairs Department, Asahi Kasei Medical Co. Ltd., Tokyo, Japan.
  • Aoki H; Japan Operation Division, Blood Purification Business Unit, Scientific and Technical Affairs Department, Asahi Kasei Medical Co. Ltd., Tokyo, Japan.
  • Sakou J; Japan Operation Division, Blood Purification Business Unit, Scientific and Technical Affairs Department, Asahi Kasei Medical Co. Ltd., Tokyo, Japan.
  • Kusada M; Japan Operation Division, Blood Purification Business Unit, Scientific and Technical Affairs Department, Asahi Kasei Medical Co. Ltd., Tokyo, Japan.
  • Maekawa T; Product Vigilance and Quality Assurance Department, Regulatory Affairs, Product Vigilance and QA Division, Asahi Kasei Medical Co. Ltd., Tokyo, Japan.
  • Hibi T; Center for Advanced IBD Research and Treatment, Kitasato University, Kitasato Institute Hospital, Tokyo, Japan. Electronic address: thibi@insti.kitasato-u.ac.jp.
J Crohns Colitis ; 8(9): 981-91, 2014 Sep.
Article em En | MEDLINE | ID: mdl-24556083

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Leucaférese Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Leucaférese Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2014 Tipo de documento: Article